Inside Innovation

Seattle-based biotech Omeros received a $6.7 million grant from the National Institute on Drug Abuse to test the company’s cocaine treatment drug candidate OMS527 in

A new report from CBRE revealed that, despite the current economic state, the life science industry’s demand for lab space is still above pre-pandemic levels

Artificial intelligence has advanced many operations and is even finding ways to revolutionize biology innovations that will accelerate drug discovery and other advances in life

The inspiration behind the Invent at Seattle Children’s Postdoctoral Scholars Program began at a workshop. Eric Nealy, who saw what the life sciences field could

David Younger, co-founder and CEO of Seattle-based biotech A-Alpha Bio is a Puget Sound Business Journal 40 under 40 honoree. Younger co-founded the company in

The inspiration behind the Invent at Seattle Children’s Postdoctoral Scholars Program began at a workshop. Eric Nealy, who saw what the life sciences field could

The Seattle-area company, Sonoma Biotherapeutics has partnered with Regeneron in a $75 million upfront deal with plans to co-develop therapies to treat Crohn’s disease and

Biotech giant Moderna is making its way to Seattle with a new office opening in South Lake Union on April 4. The company plans to

Washington remains a top life science cluster with exciting and innovative news from companies across the state. Whether it’s a record-breaking deal with Pfizer acquiring

As the global pharmaceutical market is expected to reach over $1.5 trillion by the end of 2023, life sciences is entering a new era of

The Fred Hutchinson Cancer Center revealed a $320 million clinic expansion in South Lake Union to fuel continued growth and work in cancer breakthroughs. The

After Pfizer’s $43 billion plan to buy Bothell, Wash.-based biotech giant, Seagen, Seattle-area biotech experts believe that Seagen’s technology and talent will be a great